G-rich proto-oncogenes are targeted for genomic instability in B-cell lymphomas

Cancer Research

Volumn 67, Issue 6, 2007, Pages 2586-2594

  Duquette, Michelle L ^a,b   Huber, Michael D ^a,b   Maizels, Nancy ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; CD79B ANTIGEN; DEAMINASE; FAS ANTIGEN; GUANINE NUCLEOTIDE; GUANOSINE; PROTEIN BCL 6; PROTEIN KINASE PIM 1; RHO FACTOR; TRANSCRIPTION FACTOR PAX5;

ARTICLE; B CELL LYMPHOMA; CONSENSUS SEQUENCE; CONTROLLED STUDY; DEAMINATION; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOMIC INSTABILITY; HUMAN; HYPERMUTATION; IMMUNOGLOBULIN GENE; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTO ONCOGENE; T CELL LYMPHOMA;

B-LYMPHOCYTES; GENOMIC INSTABILITY; GUANOSINE; HUMANS; IMMUNOGLOBULINS; LYMPHOMA, B-CELL; NUCLEIC ACID CONFORMATION; NUCLEOSIDE DEAMINASES; PROTO-ONCOGENES; TRANSCRIPTION, GENETIC;

EID: 34047271986     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-2419     Document Type: Article

References (50)

1. Kuppers R, Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 2001;20:5580-94.
2. Avet-Loiseau H, Gerson F, Magrangeas F, Minvielle S, Harousseau JL, Bataille R. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors. Blood 2001;98:3082-6.
3. Bergsagel PL, Kuehl WM. Chromosome translocations in multiple myeloma Oncogene 2001;20:5611-22.
4. Butler M, Corbally N, Dervan PA, Carney DN. BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL). Br J Cancer 1997;75:1641-5.
5. Akasaka T, Lossos IS, Levy R. BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood 2003;102: 1443-8.
6. Poppe B, De Paepe P, Michaux L, et al. PAX5/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements. Genes Chromosomes Cancer 2005;44:218-23.
7. Jacob AK, Sreekantaiah C, Baer MR, Sandberg AA. Translocation (1;6)(p12;p23) in ANLL. Cancer Genet Cytogenet 1990;45:67-71.
8. Dallery E, Galiegue-Zouitina S, Collyn-d'Hooghe M, et al TTF, a gene encoding a novel small G protein, fuses to the lymphoma-associated LAZ3 gene by t(3;4) chromosomal translocation. Oncogene 1995;10:2171-8.
9. Migliazza A. Martinotti S, Chen W, et al. Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci U S A 1995;92:12520-4.
10. Pasqualucci L, Migliazza A, Fracchiolla N, et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypennutation acting outside Ig loci, Proc Natl Acad Sci U S A 1998;95:11816-21.
11. Shen HM, Peters A, Baron B, Zhu X, Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypennutation of Ig genes. Science 1998;280:1750-2.
12. Peng HZ, Du MQ, Koulis A, et al, Nonimmunoglobulin gene hypermutation in germinal center B cells. Blood 1999;93:2167-72.
13. Capello D, Vitolo U, Pasqualucci L, et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood 2000;95:651-9.
14. Pasqualucci L. Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001;412:341-6.
15. Pasqualucci L, Migliazza A, Basso K, Houldsworth J, Chaganti RS, Dalla-Favera R. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood 2003;101:2914-23.
16. Gaidano G, Pasqualucci L, Capello D, et al. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood 2003;102: 1833-41.
17. Montesinos-Rongen M, Van Roost D, Schaller C, Wiestler OD, Deckert M. Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation. Blood 2004;103: 1869-75.
18. Liso A, Capello D, Marafioti T, et al. Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. Blood 2006;108:1013-20.
19. Bhatia K, Spangler G, Hamdy N, et al. Mutations in the coding region of c-myc occur independently of mutations in the regulatory regions and are predominantly associated with myc/Ig translocation. Curr Top Microbiol Immunol 1995;194:389-98.
20. Rossi D, Berra E, Cerri M, et al. Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma. Haematologica 2006;91:1405-9.
21. Chaudhuri J, Tian M, Khuong C, Chua K, Pinaud E, Alt FW. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 2003;422: 726-30.
22. Maizels N. Immunoglobulin gene diversification. Annu Rev Genet 2005;39:23-46.
23. Ramiro AR, Nussenzweig MC, Nussenzweig A. Switching on chromosomal translocations. Cancer Res 2006;66:7837-9.
24. Pham P, Bransteitter R, Petruska J, Goodman MF. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 2003;424:103-7.
25. Schwindt H, Akasaka T, Zuhlke-Jenisch R, et al. Chromosomal translocations fusing the BCL6 gene to different partner loci are recurrent in primary central nervous system lymphoma and may be associated with aberrant somatic hypermutation or defective class switch recombination. J Neuropathol Exp Neurol 2006;65:776-82.
26. Pasqualucci L, Guglielmino R, Houldsworth J, et al. Expression of the AID protein in normal and neoplastic B cells. Blood 2004;104:3318-25.
27. Ramiro AR, Jankovic M, Eisenreich T, et al. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 2004;118:431-8.
28. Park SS, Shaffer AL, Kim JS, et al. Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice. Cancer Res 2005;65:7644-52.
29. Ramiro AR, Jankovic M, Callen E, et al. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 2006;440:105-9.
30. Pham P, Bransteitter R, Goodman MF. Reward versus risk: DNA cytidine deaminases triggering immunity and disease. Biochemistry 2005;44:2703-15.
31. Duquette ML, Handa P, Vincent JA, Taylor AF, Maizels N. Intracellular transcription of G-rich DNAs induces formation of G-loops, novel structures containing G4 DNA. Genes Dev 2004;18:1618-29.
32. Maizels N. Dynamic roles for G4 DNA in the biology of eukaryotic cells. Nat Struct Mol Biol 2006;13:1055-9.
33. Phan AT, Kuryavyi V, Patel DJ. DNA architecture: from G to Z. Curr Opin Struct Biol 2006;16:288-98.
34. Duquette ML, Pham P, Goodman MF, Maizels N. AID binds to transcription-induced structures in c-MYC that map to regions associated with translocation and hypermutation. Oncogene 2005;24:5791-8.
35. Larson ED, Duquette ML, Cummings WJ, Streiff RJ, Maizels N. MutSa binds to and promotes synapsis of transcriptionally activated immunoglobulin switch regions. Curr Biol 2005;15:470-4.
36. Huber MD, Duquette ML, Shiels JC, Maizels N. A conserved G4 DNA binding domain in RecQ family helicases. J Mol Biol 2006;358:1071-80.
37. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-11.
38. Preudhomme C, Roumier C, Hildebrand MP, et al. Nonrandom 4p13 rearrangements of the RhoH/TTF gene, encoding a GTP-binding protein, in non-Hodgkin's lymphoma and multiple myeloma. Oncogene 2000;19: 2023-32.
39. Muschen M, Re D, Jungnickel B, et al. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J Exp Med 2000; 192:1833-40.
40. Gordon MS, Kanegai CM, Doerr JR, Wall R. Somatic hypermutation of the B cell receptor genes B29 (Igβ, CD79b) and mb1 (Igα, CD79a). Proc Natl Acad Sci U S A 2003;100:4126-31.
41. Landowski TH, Qu N, Buyuksal I, Painter JS, Dalton WS. Mutations in the Fas antigen in patients with multiple myeloma. Blood 1997;90:4266-70.
42. Payelle-Brogard B, Magnac C, Mauro FR, Mandelli F, Dighiero G. Analysis of the B-cell receptor B29 (CD79b) gene in familial chronic lymphocytic leukemia. Blood 1999;94:3516-22.
43. Gordon MS, Kato RM, Lansigan F, Thompson AA, Wall R, Rawlings DJ. Aberrant B cell receptor signaling from B29 (Igβ, CD79b) gene mutations of chronic lymphocytic leukemia B cells. Proc Natl Acad Sci U S A 2000;97:5504-9.
44. Shen HM, Michael N, Kim N, Storb U. The TATA binding protein, c-Myc and survivin genes are not somatically hypermutated, while Ig and BCL6 genes are hypermutated in human memory B cells. Int Immunol 2000;12:1085-93.
45. Muller JR, Janz S, Potter M. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations. Cancer Res 1995;55:5012-8.
46. Janz S. Myc translocations in B cell and plasma cell neoplasms. DNA Repair (Amst) 2006;5:1213-24.
47. Epeldegui M, Hung YP, McQuay A, Ambinder RF, Martinez-Maza O. Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations. Mol Immunol 2007;44:934-42.
48. Eddy J, Maizels N. Gene function correlates with potential for G4 DNA formation in the human genome. Nucleic Acids Res 2006;34:3887-96.
49. Sun H, Karow JK, Hickson ID, Maizels N. The Bloom's syndrome helicase unwinds G4 DNA. J Biol Chem 1998; 273:27587-92.
50. Mohaghegh P, Karow JK, Brosh Jr RM, Jr., Bohr VA, Hickson ID. The Bloom's and Werner's syndrome proteins are DNA structure-specific helicases. Nucleic Acids Res 2001;29:2843-9.